Overview Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers Status: Completed Trial end date: 2012-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the safety and pharmacokinetics following a single oral dose of MBX-400. Phase: Phase 1 Details Lead Sponsor: Microbiotix, Inc.